Recent Finacing
Recent Raise
eGenesis engineers porcine organs via CRISPR-based EGEN genome editing to remove antigen genes, insert human transgenes, and inactivate porcine retroviruses for human transplantation, advancing kidney and organ programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at EGenesis.
